John S. Brusca

Array ( [id] => 3695751 [patent_doc_number] => 05677131 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => 'System to detect protein-RNA interactions' [patent_app_type] => 1 [patent_app_number] => 8/677153 [patent_app_country] => US [patent_app_date] => 1996-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 8370 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/677/05677131.pdf [firstpage_image] =>[orig_patent_app_number] => 677153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4179367 [patent_doc_number] => 06020121 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Inhibitors of regulatory pathways' [patent_app_type] => 1 [patent_app_number] => 8/672215 [patent_app_country] => US [patent_app_date] => 1996-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 20 [patent_no_of_words] => 19175 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020121.pdf [firstpage_image] =>[orig_patent_app_number] => 672215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3823739 [patent_doc_number] => 05731181 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-24 [patent_title] => 'Chimeric mutational vectors having non-natural nucleotides' [patent_app_type] => 1 [patent_app_number] => 8/664487 [patent_app_country] => US [patent_app_date] => 1996-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12093 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/731/05731181.pdf [firstpage_image] =>[orig_patent_app_number] => 664487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3989333 [patent_doc_number] => 05891668 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Mammalian tumor susceptibility genes and their uses' [patent_app_type] => 1 [patent_app_number] => 8/670274 [patent_app_country] => US [patent_app_date] => 1996-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 14170 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891668.pdf [firstpage_image] =>[orig_patent_app_number] => 670274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3834827 [patent_doc_number] => 05712379 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-27 [patent_title] => 'Method and compositions for controlling gene expression' [patent_app_type] => 1 [patent_app_number] => 8/660275 [patent_app_country] => US [patent_app_date] => 1996-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8166 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/712/05712379.pdf [firstpage_image] =>[orig_patent_app_number] => 660275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4083636 [patent_doc_number] => 06025167 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods' [patent_app_type] => 1 [patent_app_number] => 8/671824 [patent_app_country] => US [patent_app_date] => 1996-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 40 [patent_no_of_words] => 19056 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025167.pdf [firstpage_image] =>[orig_patent_app_number] => 671824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3785225 [patent_doc_number] => 05736392 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Peptide-enhanced cationic lipid transfections' [patent_app_type] => 1 [patent_app_number] => 8/658130 [patent_app_country] => US [patent_app_date] => 1996-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 12409 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736392.pdf [firstpage_image] =>[orig_patent_app_number] => 658130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3940900 [patent_doc_number] => 05989914 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Integration cassette for improvement of transgenesis in eukaryotes' [patent_app_type] => 1 [patent_app_number] => 8/656838 [patent_app_country] => US [patent_app_date] => 1996-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6242 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989914.pdf [firstpage_image] =>[orig_patent_app_number] => 656838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3824513 [patent_doc_number] => 05759781 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Multiparametric fluorescence in situ hybridization' [patent_app_type] => 1 [patent_app_number] => 8/640657 [patent_app_country] => US [patent_app_date] => 1996-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 15 [patent_no_of_words] => 16865 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/759/05759781.pdf [firstpage_image] =>[orig_patent_app_number] => 640657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3871649 [patent_doc_number] => 05824485 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Methods for generating and screening novel metabolic pathways' [patent_app_type] => 1 [patent_app_number] => 8/639255 [patent_app_country] => US [patent_app_date] => 1996-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 25 [patent_no_of_words] => 37122 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824485.pdf [firstpage_image] =>[orig_patent_app_number] => 639255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3757168 [patent_doc_number] => 05843661 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Method for construction universal DNA based molecular turing machine' [patent_app_type] => 1 [patent_app_number] => 8/639080 [patent_app_country] => US [patent_app_date] => 1996-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 71 [patent_figures_cnt] => 80 [patent_no_of_words] => 12162 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843661.pdf [firstpage_image] =>[orig_patent_app_number] => 639080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3772582 [patent_doc_number] => 05817462 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Method for simultaneous detection of multiple fluorophores for in situ hybridization and multicolor chromosome painting and banding' [patent_app_type] => 1 [patent_app_number] => 8/635820 [patent_app_country] => US [patent_app_date] => 1996-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 53 [patent_no_of_words] => 29762 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 377 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817462.pdf [firstpage_image] =>[orig_patent_app_number] => 635820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3830780 [patent_doc_number] => 05814448 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Polymerase chain reaction/restriction fragment polymorphism method for the detection and typing of human papillomaviruses' [patent_app_type] => 1 [patent_app_number] => 8/594600 [patent_app_country] => US [patent_app_date] => 1996-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 23 [patent_no_of_words] => 18417 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814448.pdf [firstpage_image] =>[orig_patent_app_number] => 594600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1484667 [patent_doc_number] => 06365344 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'Methods for screening for transdominant effector peptides and RNA molecules' [patent_app_type] => B1 [patent_app_number] => 08/589109 [patent_app_country] => US [patent_app_date] => 1996-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 5676 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365344.pdf [firstpage_image] =>[orig_patent_app_number] => 08589109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619457 [patent_doc_number] => 05614413 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'Encapsidated recombinant poliovirus nucleic acid and methods of making and using same' [patent_app_type] => 1 [patent_app_number] => 8/589446 [patent_app_country] => US [patent_app_date] => 1996-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 36 [patent_no_of_words] => 14215 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614413.pdf [firstpage_image] =>[orig_patent_app_number] => 589446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3692022 [patent_doc_number] => 05679523 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Method for concurrent disruption of expression of multiple alleles of mammalian genes' [patent_app_type] => 1 [patent_app_number] => 8/585758 [patent_app_country] => US [patent_app_date] => 1996-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10230 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679523.pdf [firstpage_image] =>[orig_patent_app_number] => 585758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3753561 [patent_doc_number] => 05843426 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Salmonella vaccines' [patent_app_type] => 1 [patent_app_number] => 8/565861 [patent_app_country] => US [patent_app_date] => 1995-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 25 [patent_no_of_words] => 37869 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843426.pdf [firstpage_image] =>[orig_patent_app_number] => 565861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3887265 [patent_doc_number] => 05834233 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Method of limiting the survival of genetically engineered microorganisms in their enivronment' [patent_app_type] => 1 [patent_app_number] => 8/544822 [patent_app_country] => US [patent_app_date] => 1995-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34840 [patent_no_of_claims] => 125 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/834/05834233.pdf [firstpage_image] =>[orig_patent_app_number] => 544822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3744701 [patent_doc_number] => 05716847 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-10 [patent_title] => 'Buffered embryo solutions' [patent_app_type] => 1 [patent_app_number] => 8/539679 [patent_app_country] => US [patent_app_date] => 1995-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2352 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/716/05716847.pdf [firstpage_image] =>[orig_patent_app_number] => 539679 [rel_patent_id] =>[rel_patent_doc_number] =>)